在一般实践中患有喘的成年人中在线喘教育计划的有效性:来自集群随机对照试验的结果
Stefanie Eck1, Andrea Baumgärtel1, Alexander Hapfelmeier2
1Institute of General Practice and Health Services Research, Department Clinical Medicine, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Respiratory medicine
|March 15, 2025
概括
在线喘教育计划 (eAEP) 在六个月内显著改善了成年人的喘知识和症状控制. 这种数字工具显示了在一般诊所环境中改善喘护理的前景.
科学领域:
- 肺部病理学 肺部病理学
- 数字健康数字健康
- 卫生教育卫生教育教育
背景情况:
- 传统的喘教育计划 (AEP) 的患者参与度很低.
- 为了解决可访问性障碍,开发了一个电子AEP (eAEP).
- 在患有喘的成年人中,eAEPs的有效性需要研究.
研究的目的:
- 评估eAEP对喘知识的影响.
- 评估eAEP对喘患者症状控制的影响.
- 确定eAEP对紧急治疗利用的影响.
主要方法:
- 采用了一个集群随机对照试验设计.
- 一般医生 (GP) 的实践被随机分为eAEP干预或常规护理 (UC).
- 包括喘知识测试 (AKT) 和喘控制测试 (ACT) 分数在内的结果在基线和随访点被测量到六个月.
主要成果:
- 与UC组相比,eAEP组在AKT得分上显示出明显更大的改善.
- 在eAEP组中观察到通过ACT测量对症状控制的有益影响.
- 干预组的患者表现出更好的吸入技巧,接受了更多的峰值呼气流动指令,并且更有可能有一个喘行动计划.
结论:
- 在六个月的时间内,eAEP有效地提高了喘知识并改善了症状控制.
- 这些发现表明,eAEPs可以在GP环境中对喘管理做出积极贡献.
- 数字喘教育提供了一个可扩展的解决方案,以改善患者的治疗结果.
相关概念视频
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Antiasthma Drugs: β2-Adrenoceptor Agonists
208
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
208


